DnB Asset Management’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-267,568
Closed -$1.08M 736
2025
Q2
$1.08M Buy
267,568
+7,397
+3% +$24.1K ﹤0.01% 616
2025
Q1
$710K Buy
260,171
+32,900
+14% +$118K ﹤0.01% 639
2024
Q4
$966K Buy
+227,271
New +$865K ﹤0.01% 638
2022
Q1
Sell
-76,768
Closed -$678K 648
2021
Q4
$678K Buy
+76,768
New +$730K ﹤0.01% 640

Other funds holding SRTA

DnB Asset Management's SRTA Position: Q3 2025 in Review

DnB Asset Management sold out of Strata Critical Medical Inc (SRTA) in Q3 2025, closing a stake of 267,568 shares — an estimated $1.08M sold.

DnB Asset Management first reported a position in SRTA in Q4 2021 and held it in 4 quarters. The position peaked at $1.08M in Q2 2025. 137 funds tracked by Wall St. Rank hold SRTA as of Q3 2025.

  • DnB Asset Management reported no remaining Strata Critical Medical Inc position as of Q3 2025 after selling out during the quarter.
  • DnB Asset Management sold 267,568 Strata Critical Medical Inc shares in Q3 2025, an estimated $1.08M.
  • DnB Asset Management first reported a position in Strata Critical Medical Inc in Q4 2021 and held it in 4 quarters.
  • DnB Asset Management's Strata Critical Medical Inc position peaked at $1.08M in Q2 2025.
  • 137 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q3 2025.

Based on DnB Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.